Cain G D, Mayer G, Jones E A
J Clin Invest. 1970 Dec;49(12):2198-204. doi: 10.1172/JCI106438.
Simultaneous studies of albumin and fibrinogen metabolism have been conducted using the carbonate-(14)C method before and after a 13 day course of prednisolone in eight patients with hepatocellular disease. Initially six patients were hypoalbuminemic. The mean plasma albumin and fibrinogen concentrations and albumin and fibrinogen synthetic rates were all lower than the corresponding values in a group of control subjects. Prednisolone therapy was associated with significant increases in the plasma concentration and synthetic rate of albumin but changes in the intravascular albumin pools were not significant. It is inferred that a low synthetic rate of albumin in a patient with liver disease does not necessarily represent the maximum capacity of the diseased liver to synthesize this protein. Changes in the plasma concentration, intravascular pool, and synthetic rate of fibrinogen were small and inconsistent. The data are compatible with a selective action of corticosteroids on hepatic protein metabolism and with the existence of different mechanisms for the control of albumin and fibrinogen synthesis.
在8例肝细胞疾病患者中,采用碳酸盐 - (14)C方法,在泼尼松龙治疗13天疗程前后,对白蛋白和纤维蛋白原代谢进行了同步研究。最初,6例患者存在低白蛋白血症。血浆白蛋白和纤维蛋白原浓度以及白蛋白和纤维蛋白原合成率的平均值均低于一组对照受试者的相应值。泼尼松龙治疗与血浆白蛋白浓度和合成率的显著增加相关,但血管内白蛋白池的变化不显著。据推断,肝病患者白蛋白合成率低不一定代表患病肝脏合成该蛋白的最大能力。纤维蛋白原的血浆浓度、血管内池和合成率的变化较小且不一致。这些数据与皮质类固醇对肝脏蛋白质代谢的选择性作用以及控制白蛋白和纤维蛋白原合成的不同机制的存在相一致。